Ocrevus - Are most insurance carriers approving this medicine ?
Question posted by Anitapdm on 29 March 2017
Last updated on 18 March 2020 by streetstock14
Answers
streetstock14
18 March 2020
I want to know if medicare and blue cross covers this for people over 65
suzanne66
29 May 2017
The FDA has approved Ocrevus (ocrelizumab) for the treatment of adults with primary progressive MS and with relapsing MS.
List cost is $65,000 per year so access will depend on individual insurance plans.
For people who qualify, Genentech plans to offer patient assistance programs through Genentech Access Solutions: (866) 4ACCESS/(866) 422-2377 or http://www.Genentech-Access.com.
Related topics
Further information
- Ocrevus uses and safety info
- Ocrevus prescribing info & package insert (for Health Professionals)
- Side effects of Ocrevus (detailed)
Similar questions
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
